Stoke Therapeutics, Inc. SEC filings STOK
Stoke Therapeutics, Inc. has 632 filings in SEC EDGAR's recent list, going back to Nov 24, 2014. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 7, 2026 | Apr 3, 2026 |
| 8-K |
Current report
Auditor change
|
Mar 27, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jan 26, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2025 | Dec 5, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2025 | Oct 5, 2025 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 18, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2025 | Jul 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Feb 18, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 6, 2024 | Dec 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 28, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2024 | Mar 25, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 14, 2023 | Dec 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 1, 2023 | Dec 1, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Oct 26, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2023 | Sep 19, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 3, 2023 | Feb 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2022 | Dec 2, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 20, 2022 | May 20, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Listing notice
|
Feb 17, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 9, 2022 |
| 8-K | Current report | Dec 17, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Other events
|
Dec 3, 2021 | Dec 3, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Other events
|
Sep 21, 2021 | Sep 21, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 9, 2021 | Sep 8, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2021 | Mar 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 5, 2021 | Feb 5, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2020 | Nov 19, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Other events
|
Oct 7, 2020 | Oct 7, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2020 | Aug 17, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2020 | Aug 13, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure
|
Jun 4, 2020 | Jun 3, 2020 |
| 8-K |
Current report
Results of operations
|
May 15, 2020 | May 15, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2020 | May 12, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 15, 2020 | Apr 14, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2020 | Mar 23, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 9, 2019 | Dec 7, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2019 | Aug 14, 2019 |
Showing 86 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- STOK (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedford, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1623526
- Former names
- ASOthera Pharmaceuticals, Inc. (until Nov 24, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.